Adverse Effects

Citations 371-380 of 590 total displayed.

Past content (since Mar 1998):

Letters
The RADAR Project and the FDA—Reply

Charles L. Bennett; Jonathan R. Nebeker; Dennis W. Raisch
JAMA 2005; 294: 1206-a-1207-a. [Extract] [Full text] [PDF]  

Letters
The RADAR Project and the FDA

Anne E. Trontell
JAMA 2005; 294: 1206. [Extract] [Full text] [PDF]  

Health Agencies Update
Fentanyl Patch Advisory

Tracy Hampton
JAMA 2005; 294: 893-b. [Extract] [Full text] [PDF]  

Letters
Risk of Death With Nesiritide

Justine Schuller Gortney; Kalen B. Porter
JAMA 2005; 294: 897-a-898-a. [Extract] [Full text] [PDF]  

Letters
Risk of Death With Nesiritide

Andrew J. Burger
JAMA 2005; 294: 897. [Extract] [Full text] [PDF]  

Letters
Risk of Death With Nesiritide—Reply

Jonathan D. Sackner-Bernstein; Keith Aaronson
JAMA 2005; 294: 898. [Extract] [Full text] [PDF]  

Capitol Health Call
Off-Label Promotion

Bridget M. Kuehn
JAMA 2005; 294: 673-c. [Extract] [Full text] [PDF]  

Original Contributions
Childhood Vaccination and Nontargeted Infectious Disease Hospitalization

Anders Hviid; Jan Wohlfahrt; Michael Stellfeld; Mads Melbye
JAMA 2005; 294: 699-705. [Abstract] [Full text] [PDF]  

Reviews
Duration of Anticoagulation Following Venous Thromboembolism: A Meta-analysis

David Ost; Josh Tepper; Hanako Mihara; Owen Lander; Raphael Heinzer; Alan Fein
JAMA 2005; 294: 706-715. [Abstract] [Full text] [PDF]  

Contempo Updates
Malignant Hyperthermia: Update on Susceptibility Testing

Ronald S. Litman; Henry Rosenberg
JAMA 2005; 293: 2918-2924. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59